What should we report? Lessons learnt from the development and implementation of serious adverse event reporting procedures in non pharmacological trials in palliative care BMC Palliative Care Springer Nature Link Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] Preprints.org Long Term Side Effects of Immune Checkpoint Inhibitors NCI CJC 1295: Popular Claims vs What Evidence Requires, CJC 1295 (often paired with ipamorelin) is marketed for fat loss, lean mass, recovery, sleep, and energy, based on its growth hormone axis A 50 year journey in the development of treatment for benign prostatic hyperplasia npj Aging From toxicity assessment to adaptive safety care: implementing comprehensive fast track safety evaluation for anticancer drug development ESMO Open